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Abstract Pollen allergens are one of the main causes of type I
allergies affecting up to 30 % of the population in industrial-
ized countries. Climatic changes affect the duration and inten-
sity of pollen seasons and may together with pollution con-
tribute to increased incidences of respiratory allergy and asth-
ma. Allergenic grasses, trees, and weeds often present similar
habitats and flowering periods compromising clinical anam-
nesis. Molecule-based approaches enable distinction between
genuine sensitization and clinically mostly irrelevant IgE
cross-reactivity due to, e. g., panallergens or carbohydrate
determinants. In addition, sensitivity as well as specificity
can be improved and lead to identification of the primary
sensitizing source which is particularly beneficial regarding
polysensitized patients. This review gives an overview on
relevant pollen allergens and their usefulness in daily practice.
Appropriate allergy diagnosis is directly influencing decisions
for therapeutic interventions, and thus, reliable biomarkers are
pivotal when considering allergen immunotherapy in the con-
text of precision medicine.
Keywords Pollen allergens .Molecule-based diagnosis .
Grass pollen allergens . Tree pollen allergens .Weed pollen
allergens
Introduction
Allergic reactions to pollen represent the most frequent type I
allergies affecting up to 30 % of the industrialized population
(www.eaaci.org). Climatic changes are expected to influence
the duration as well as the intensity of pollen seasons which
might in hand with air pollution contribute to increased
numbers of respiratory allergy and asthma [1, 2]. In addition,
pollen-derived nanovesicles and other small components (e.g.,
adenosine) may play a specific role in the course of allergic
diseases [3, 4]. Clinical anamnesis of pollen allergies to identify
the disease-eliciting source can be hampered by similar
habitat and flowering periods of certain plants and the fact that
symptoms may be elicited by pollen transported far by the
wind [5]. In addition, patients are often multi-sensitized to
diverse allergen sources due to IgE cross-reactivity, co-sensi-
tization, or both [6–10]. Skin prick tests and specific IgE de-
tection using crude pollen extracts are currently performed in
routine allergy diagnosis. Allergen extracts however contain a
variety of allergenic and non-allergenic components, and stan-
dardization of pollen extracts is difficult due to varying source
material and product preparations [11]. Besides source specif-
ic and thus genuine marker allergens, also minor allergens
including panallergens as wells as allergens with cross-
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reactive carbohydrates (CCDs) are present in diagnostic ex-
tracts which might impede exact diagnosis. Molecular diag-
nosis using well-characterized purified allergen components
from natural source or produced as recombinant molecule
allows clinicians to obtain detailed information on sensitiza-
tion profiles and thus supports improved patients’ manage-
ment [11, 12•].
More than 150 pollen allergens are officially acknowl-
edged by the IUIS allergen nomenclature sub-committee orig-
inating from grasses, trees, and weeds (www.allergen.org).
This review focuses on the most relevant and commercially
available components which are discussed in more detail
(Tables 1 and 2). We also provide an overview on diverse
IgE cross-reactivity profiles within the Ole e 1-like,
pectate lyase and non-specific lipid transfer protein
(nsLTP) families (Fig. 1).
Methods for Molecule-Based Allergy Diagnosis
Apart from clinical history, skin prick tests (SPT) using aller-
gen extracts represent one of the most common used in vivo
diagnostic tools to confirm an immediate IgE-mediated aller-
gic reaction. Since the 1990s, the performance of several pu-
rified recombinant pollen allergens was investigated in prov-
ocation tests and compared to natural allergens and extracts
[13•]. Though refinement of diagnosis with purified mole-
cules was proven effective, in vivo diagnosis using compo-
nents is nowadays widely restricted to GMP-produced mate-
rial. Alternatives such as the basophil activation test (BAT), an
in vitro method to monitor upregulation of activation markers
CD63 and CD203 upon allergen-triggered activation of pri-
mary basophils, or mediator release assays with passively sen-
sitized basophils, which measure either histamine or β-hexos-
aminidase, may help to circumvent this problem. While these
assays demonstrate functional allergen responses, they are
rather demanding regarding the costs and experimental skills
and thus are not used in daily practice. Measurement of spe-
cific IgE (sIgE) in serum is currently the most widely used
in vitro method for allergy diagnosis. Besides allergen extracts
provided for singleplex analyses (ImmunoCAP), a panel of
purified natural and recombinant components is commercially
available for routine diagnosis. In addition, allergen mi-
croarrays with more than 100 purified allergen mole-
cules (ImmunoCAP ISAC) enable simultaneous IgE
measurement using only minute amounts of blood.
These multiplex assays offer an attractive alternative to
refine allergy diagnosis, monitor disease progression as
well as therapeutic outcomes [14]. All in vitro methods
provide reliable information on IgE sensitization while
correlation with clinically relevant symptoms remains
challenging [15]. Ta
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Grass Pollen Allergens
Grasses are cultivated for food, animal fodder, surface vege-
tation, and meadows, but also represent one of the major
causes of respiratory allergies worldwide [16–19]. The clini-
cally most relevant source of pollen allergens is found within
the Poaceae family. Among this, the Pooideae subfamily is
prevalent in temperate climates and the most abundant aller-
genic species within the Pooideae are Timothy grass,
Perennial ryegrass, Orchard grass, and Kentucky blue grass.
The pollination season typically starts in spring and lasts until
late summer, pollen peaks are usually found between June and
July. In subtropical regions, members of the Chloridoideae
and Panicoideae subfamilies are widely distributed. Here,
the most important species triggering pollen allergy are
Bermuda grass, Bahia grass, and Johnson grass [20].Ta
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a  Ole e 1-like family
b  Pectate lyases
c  Lipid transfer proteins
Ole e 1
Fra e 1 87
Pla l 1 37 38
Che a 1 37 38 34
Sal k 5 37 39 36 72
Phl p 11 31 34 29 46 45
Ole e 1   Fra e 1   Pla l 1   Che a 1   Sal k 5   Phl p 11
Amb a 1
Art v 6 59
Cup a 1 46 48
Cup s 1 44 46 95
Cry j 1 46 47 79 78
Jun a 1 45 46 95 96 79
Amb a 1   Art v 6   Cup a 1  Cup s 1  Cry j 1   Jun a 1
Art v 3
Amb a 6 35
Par j 2 30 33
Ole e 7 25 29 10
Pla a 3 53 37 32 33
Pru p 3 49 36 24 20 53
Art v 3   Amb a 6   Par j 2   Ole e 7   Pla a 3   Pru p 3
Fig. 1 Sequence identity matrix and 3D-models of allergenic protein
families. a Ole e 1-like proteins and structure of Pla l 1.0101 (4Z8W), b
pectate lyases and model of Amb a 1.0101 (template 1PXZ), and c lipid
transfer proteins and model of Art v 3.0201 (template 2B5S). Multiple
sequence alignments performed in Clustal Omega. Models were generated
using Swiss-Model (www.swissmodel.expasy.org), and ribbon cartons
are shown using UCSF Chimera (www.cgl.ucsf.edu/chimera). Green
boxes represent demonstrated IgE cross-reactivity, light green boxes
represent potential IgE cross-reactivity based on high sequence identity,
red boxes represent no/limited demonstrated IgE cross-reactivity and light red
boxes represent no/limited IgE cross-reactivity based on low sequence
identity
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Pollination of these grasses persists throughout the year
peak ing f rom ear ly summer th rough au tumn.
Climatological changes due to global warming and hu-
man activities have additionally influenced pollen distri-
bution as well as potency which further increases sensi-
tization risks [21••].
Timothy Grass
Timothy grass is widely distributed in the temperate climate
and one of the best characterized allergenic grasses. The
highest sensitization prevalence is registered in the European
population, ranging from 18.5 to 28.5 % [6]. A prevalence of
36 % among Austrian pupils was recently found using aller-
gen microarray analysis (Stemeseder et al., unpublished). The
majority of commercially available components for grass pol-
len allergy originate from Timothy grass (Table 1). In this
context, Phl p 1, a major allergen from Timothy grass with a
sensitization prevalence of >90 % among grass pollen allergic
patients, seems extremely important [22, 23]. Phl p 1-specific
IgE is considered a marker for genuine sensitization and was
recently also proposed as Binitiator molecule^ for Timothy
grass pollen allergy [21••, 24••]. In the study by Hatzler
et al., 75 % of grass pollen allergic patients started with
mono-sensitization to Phl p 1, in some cases years before
onset of clinical symptoms, which subsequently developed
into poly-sensitization towards other grass pollen aller-
gens [24••].
The second major allergen in this source is Phl p 5, trigger-
ing specific IgE in 65–90 % of grass pollen allergic patients.
Together with Phl p 1, it is considered a marker molecule for
grass pollen allergy, and in rare cases of absent Phl p 1-specific
IgE, Phl p 5 is giving reliable results of genuine sensitization
[21••, 22]. Phl p 5 is highly cross-reactive with other group 5
grass pollen allergens, which are restricted to grasses of the
Pooideae subfamily [25•, 26]. A high sequence homology
with Phl p 6 is observed, and significant levels of IgE cross-
reactivity have been demonstrated [26]. Phl p 6 is frequently
used together with Phl p 2 and Phl p 5 to confirm specific
sensitization to Pooideae grasses [21••]. However, care should
be taken with interpretation of Phl p 2 results since a homol-
ogous molecule termed Sor h 2 was recently identified in
Johnson grass, a member of the Panicoideae subfamily
[25•]. The tentatively termed Timothy grass pollen allergen
Phl p 3 shows sequence identity with Phl p 2 and partially
with the C-terminus of Phl p 1; however, while cross-
reactivity between group 2 and 3 grass pollen allergens was
demonstrated, relevant cross-reactivity to group 1 allergens is
not evident [27].
Among grass pollen components, solely Phl p 4 is provided
as natural protein harboring CCDs. Recombinant Phl p 4 dem-
onstrates lower IgE reactivity, thus IgE-binding to commer-
cially available natural Phl p 4 should be analyzed for CCDs
reactivity [7, 28]. In Timothy grass, the panallergens Phl p 7
(polcalcin) and Phl p 12 (profilin) are present probably
inducing IgE cross-reactivity with homologs from trees,
weeds and foods [29]. In the absence of Phl p 1- and/or
Phl p 5-specific IgE, sensitization to panallergens is not
indicative of genuine grass pollen reactivity [21••].
Nevertheless, an association of the Phl p 12 sensitiza-
tion and the development of oral allergy syndromes
were demonstrated in Italian children [30]. Due to the
low sequence similarity, IgE cross-reactivity of Phl p 11
with other Ole e 1-like family members from trees and
weeds is absent or very limited [29] (Stemeseder et al.,
unpublished).
Perennial Ryegrass, Orchard Grass, and Kentucky Blue
Grass
Allergens from Perennial ryegrass, Orchard grass, and
Kentucky blue grass have been identified and are listed in
Table 1, but none of those is commercially available for diag-
nosis. Due to high sequence identity and extensive IgE cross-
reactivity of allergens within the Pooideae subfamily, diagno-
sis to temperate grasses is usually performed with components
from Timothy grass [21••, 25•, 26, 31].
Bermuda Grass
Cyn d 1, the major allergen from Bermuda grass, is currently
the only commercially available molecule of the subtropical
grasses. It is considered as biomarker for genuine sensitization
to the Chloridoideae subfamily [21••]. Cyn d 1 is recognized
by 76–100 % of grass pollen allergic patients, which may also
result in IgE cross-reactivity with Phl p 1 [31]. Therefore, it
was suggested that the primary sensitization to Bermuda grass
is indicated when specific IgE-levels to Cyn d 1 exceed IgE-
binding to Phl p 1 and IgE to Phl p 5 is not detectable. Since
Cyn d 1 is harboring CCDs, glycan-derived reactivity should
be monitored during diagnosis [7].
Bahia Grass and Johnson Grass
Currently, no allergen from the Panicoideae subfamily is com-
mercially available for molecular diagnosis. In recent years, a
growing number of allergens from these sources have been
described. Timbrell et al. showed improved sensitivity and
specificity when using nPas n 1 for molecular diagnosis of
Bahia grass pollen allergic patients [32•]. The authors sug-
gested to include the Pas n 1 for commercially available diag-
nosis of Bahia grass allergy as a sub-group of patients showed
species-specific IgE and T cell reactivity [33, 34]. As men-
tioned above, Sor h 2 was recently identified in Johnson grass
which refutes the assumption that group 2 allergens are absent
in subtropical grasses [21••, 25•, 35].
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Tree Pollen Allergens
In general, trees are woody perennial plants with an elongated
self-supporting stem or trunk and supporting branches that
form a more or less defined crown. To distinguish trees from
shrubs, a certain stem height or diameter is sometimes used as
decision criteria. Trees do not comprise a single taxonomic
group and include various species that separately evolved
stems and branches [36]. Most of the clinically relevant pollen
allergens are produced by wind-pollinated trees belonging to
only four different orders, which show an almost worldwide
distribution. For details on tree pollen allergens, review Asam
et al. [37••].
Birch and Related Fagales Species
Classified within the order of Fagales, birch and the related
tree species alder, hornbeam, hop-hornbeam, hazelnut, beech,
chestnut, and oak constitute the main cause of early seasonal
rhinitis in the temperate climate zone of the Northern
Hemisphere [8]. Worldwide, more than 100 million patients
suffer from birch pollen allergies and in Europe clinically
relevant sensitization to birch affects around 19.6 % of the
allergic population. Clinically relevant sensitization rates to
hazel and alder pollen were reported at 17.1 and 16.2 %, re-
spectively [38••, 39]. The major allergens from Fagales trees
are classified as members of the pathogenesis-related-10 (PR-
10) proteins, and Bet v 1 from birch pollen is generally ac-
knowledged as main sensitizer and marker allergen of this
family (Table 2). Among birch pollen allergic individuals,
sensitization rates to Bet v 1 of up to 90 % or more have been
reported [40, 41]. However, inhibition experiments revealed
that besides birch, several other Fagales species might have
the potential to sensitize susceptible individuals [9]. This
seems especially important in areas where birch trees are vir-
tually absent, thus exposure to other allergenic Fagales pollen
will eventually lead to sensitization and the development of
Fagales pollen allergy. Currently, Bet v 1 is the only group 1
Fagales allergen offered for singleplex, while Aln g 1 and Cor
a 1 are additionally available for multiplex analysis. Since oak
populations are very wide-spread not only in Europe but also
in vast parts of North America and Asia and do not necessarily
coexist with birch or hazel, Que a 1 should be considered for
diagnosis especially in those areas. More than 70 % of birch
pollen allergic patients develop adverse symptoms to food
such as fruits, nuts, or vegetables [42]. This clinical
condition often referred to as pollen-food syndrome al-
ways involves a pre-sensitization to Fagales pollen al-
lergens [43]. Therefore, diagnosis of Bet v 1-related
food allergies is directly linked to a correct diagnosis
of the underlying pollen allergy. Moreover, several mi-
nor allergens, among them the panallergens profilin and
polcalcin, have been identified in many allergenic
Fagales species, evoking sensitization rates of 44.6 and
9.4 %, respectively [44].
Plane Tree
Plane trees belong to the order of Proteales and are native to
the Northern Hemisphere. They preferentially grow in tem-
perate regions from Asia to Europe and North America. Due
to their resistance towards pollution, they are widely used as
ornamental trees in urban areas and at roadsides [45, 46].With
3.3 % in the allergic population, clinically relevant sensitiza-
tion throughout Europe is rather low but can reach almost
12 % in the UK [38••]. More than 80 % of plane-sensitized
patients react to the major allergens Pla a 1 (plant invertase
inhibitor) and Pla a 2 (polygalacturonase) [45, 47, 48]. The
minor allergen Pla a 3 is a member of the nsLTP family and
shows high cross-reactivity with Pru p 3, the major allergen
from peach [49].
Olive, Ash, Lilac, and Privet
The major allergy-eliciting species within the order of
Lamiales are olive, ash, lilac, and privet. Olive trees are pref-
erentially cultivated in the Mediterranean area where up to
70 % of patients with respiratory symptoms are sensitized to
olive pollen [8]. With a sensitization prevalence of 80 %
among olive pollen allergic patients, Ole e 1 represents the
major allergen and thus is the eponym of the Ole e 1-like
protein family with homologs in tree, grass, and weed pollen.
While cross-reactivity to homologues in other Oleaceae trees
is very high, cross-reactivity with grass (Phl p 11) and weed
(e.g., Pla l 1) Ole e 1-like allergens is limited [37••]
(Stemeseder et al., unpublished). Besides Ole e 1, 10 other
olive pollen allergens, including the panallergens Ole e 2
(profilin) and Ole e 3 (polcalcin), have been described and
details can be reviewed in Villalba et al. [50•]. Depending
on geographic location and thus on the exposure level of the
population, the allergens Ole e 6, 7, 10, and 11 may eventually
become major allergens of olive pollen [50•, 51].
In central Europe, ash pollen may cause sensitization rates
from 4 to 18 % [37••]. The major allergen of European ash,
Fra e 1, has been classified as member of the Ole e 1-like
family and shows high sequence similarity to other Ole e 1-
like proteins from Lamiales [52]. A recent study from Imhof
et al. confirmed the high cross-reactivity between Ole e 1 and
Fra e 1 and suggested using Ole e 1 as diagnostic maker of ash
pollen allergy [53]. Moreover, a β-1,3-glucanase from ash
termed Fra e 9 was recently identified, which can account
for a sensitization prevalence up to 60 % in distinct areas of
France [54]. Common privet as well as lilac are often used for
ornamental purposes and frequently found in Europe, Asia,
and North America. Both express highly cross-reactive major
allergens belonging to the Ole e 1-like protein family (Lig v 1
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and Syr v 1, respectively); sensitization rates are however
generally low [55].
Allergenic Cypress Species, Japanese Cedar, and Juniper
Trees
The order of Pinales comprises allergenic cypress, cedar as
well as juniper species. In contrast to the previously described
allergenic trees, Pinales are gymnosperms widely distributed
throughout the Northern Hemisphere. Mediterranean cypress
and its American relative, Arizona cypress, which is primarily
native to the south-west of North America, are closely related
to evergreen trees which coexist in the Mediterranean area
(www.eol.org). Among the allergic individuals in Europe, 2.
6 % show a clinically relevant sensitization to cypress, which
is generally low, however, may reach levels of up to 42.7 % as
reported for allergic patients in Italy [56]. The major allergens
of both species, Cup s 1 and Cup a 1, belong to the pectate
lyase family and share 95.1 % sequence identity. Moreover,
clinically relevant, highly cross-reactive, allergenic pectate
lyases have been identified as major allergens in Mountain
cedar (Jun a 1) endemic in the USA, as well as in Japanese
cypress (Cho o 1) and Japanese cedar (Cry j 1). The latter two
species form dominant populations on the Japanese island
[37••]. Sensitization rates evoked by Cha o 1 or the more
potent Cry j 1 affect up to 40 % of the population in certain
areas of Japan [57, 58], whereas sensitization to Jun a 1
represents a serious health risk in Texas and Mexico [59].
Moreover, the polygalacturonases Jun a 2, Cry j 2 and Cha o
2, have been identified as major allergens in these
Cupressaceae species being responsible for sensitization
rates of up to 80 % [37••, 60, 61]. Nevertheless, allergenic
polygalacturonases did not get much attention so far but
should eventually be considered as candidates for allergy
diagnosis.
Weeds Pollen Allergens
The term Bweed^ does not refer to any specific botanical fam-
ily but rather describes plants outside the order of trees or
grasses. They are used as culinary herbs, medicinal plants, and
are frequently ecologically adaptive segetal plants [62]. Climatic
changes are generally impacting the flora, which might be par-
ticularly advantageous for weeds as they are able to dominate
groundcover, adapt to various environments, or reside in ecologic
niches. Weed pollen allergic patients are frequently poly-
sensitized to diverse plant sources, thus molecule-based ap-
proaches are especially valuable for precise diagnosis. A com-
prehensive overview on production and botanical classification
of weed pollen allergens is provided in Gadermaier et al.
and Villalba et al. [63, 64•].
Ragweed
Short ragweed is native to Northern and Central America,
where it is one of the major elicitors of type I pollen allergy.
Sensitization prevalence can be up to 15.3 % in the general
population and the weed demonstrates high cross-reactivity
with other Ambrosia spp. [65–67]. Since its introduction as
ballast grain, ragweed also became a relevant allergen source
in parts of Europe, Asia, and Australia [5, 68]. Global
warming already substantially prolonged the ragweed pollen
season and further spreading of the weed to the North is pre-
dicted by in silico models [69, 70].
The pectate lyase Amb a 1 is highly abundant in ragweed
pollen and represents the dominant allergen. Based on a sen-
sitization prevalence of >95%, the natural allergen is currently
considered the marker allergen for genuine ragweed sensitiza-
tion [63, 71]. In contrast to lacking cross-reactivity to homo-
logs from the Cupressaceae family, antibody cross-reactivity
with Art v 6 from mugwort pollen is observed. However,
inhibition assays and T cell studies primarily point at a stron-
ger allergenic potential and sensitizing role of Amb a 1 [72,
73]. In a recent study, primary sensitizing capacity of Art v 6
was also demonstrated and the authors concluded that true co-
sensitization of ragweed and mugwort is generally rare [10].
Recently, a cysteine protease with structural homology to
group I allergens from house dust mites was identified in
ragweed and designated Amb a 11 [74••]. It represents also a
major allergen since 66 % of patients reacted to the molecule,
which was previously Bhidden^ in the Amb a 1 fraction.
Though the majority of allergenic reactivity is clearly attribut-
ed to Amb a 1 and isolated Amb a 11 reactivity seems rare, it
could be relevant for increasing the diagnostic panel [74••].
The minor ragweed allergen Amb a 4 consists of a defensin-
like domain fused with a proline-rich region with homology
and IgE cross-reactivity to Art v 1 from mugwort pollen [75].
Ragweed allergens belonging to the profilin, polcalcin, and
nsLTP families (Table 2) are accounting for moderate to low
IgE reac t iv i t y [63 ] . Recen t t r an sc r ip tome and
immunoproteome data suggest 68 and 41 % IgE reactivity
for ragweed polygalacturonase and enolase, respectively
[71], which together with Amb a 3 might be worth investigat-
ing at the molecule level.
Mugwort
Common mugwort is endemic in the Northern Hemisphere and
Australia and represents the best studied plant within the genus.
Among pollinosis patients, sensitization to mugwort pollen
ranges between 10 and 14 % in the European and Asian
population [63, 76]. Habitat and pollination of mugwort are
vastly overlapping with ragweed and thus confounding aller-
gy anamnesis. Art v 1, consisting of a defensin-like domain
fused with a proline-rich region, represents the major allergen
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with a sensitization prevalence of 70–95 % [77, 78]. The mark-
er allergen demonstrates partial IgE cross-reactivity with Amb
a 4 from ragweed and Par h 1 from feverfew pollen. Primary
sensitization seems to be predominately evolving by the major
mugwort allergen (Pablos et al., unpublished data). In addition,
Art v 3 is of particular interest in regions where nsLTP-related
food and pollen allergies are observed [79]. While Art v 3
might pave the way to food-related symptoms in peach allergic
patients [80], recent data also suggest that it is able to bona fide
elicit respiratory symptoms in patients [81, 82•]. In mugwort
sensitized patients, Art v 6 in hand with Art v 1 is considered
highly indicative for primary mugwort sensitization [10].
Pellitory
Pollen of pellitory is responsible for allergic reactions predom-
inately in Mediterranean regions with sensitization frequen-
cies reaching 60–90 % [63]. Due to climatic changes,
flowering periods throughout the year were registered [83].
The main allergen components are Par j 1 and Par j 2, both
belonging to the nsLTP family showing a sensitization fre-
quency of up to 95 % [63, 84]. They are considered marker
allergens for genuine pellitory allergy, since they do not cross-
react with homologs from other pollen and food [85]. Par j 2
showed high sensitivity and specificity and is currently used
for routine molecule-based diagnosis of pellitory [86].
English Plantain
Plantago spp. are worldwide abundant weeds showing recur-
rent flowering seasons overlapping with grasses. Studies dem-
onstrated a high clinical relevance in parts of southern and
central Europe [87•, 88]. The major allergen Pla l 1 belongs
to the Ole e 1-like family and is recognized by >90 % of
patients [63, 87•]. Since IgE cross-reactivity with other family
members is limited, it represents a highly specific marker for
molecule-based diagnosis [62] (Stemeseder et al.,
unpublished).
Russian Thistle and Goosefoot
These weeds are considered invasive species found in arid
regions of the Northern Hemisphere and Australia [62, 64•].
Due to their previous use in greening programs, they are high-
ly abundant in Middle Eastern countries where they can rep-
resent major sensitizers for rhinitis and asthma [64•, 89, 90].
Amaranthaceae pollen also gained allergological relevance in
areas of Spain, and they are expected to play an increasingly
important role [91, 92]. The pectin methylesterase Sal k 1
accounts for the majority of IgE reactivity to Russian thistle
and was shown to be a marker for genuine sensitization as it
allows discrimination from chenopod sensitization [93, 94].
Natural glycosylated Sal k 1 is currently available for
molecule-based diagnosis; however, the use of a recombinant
molecule might be superior as CCDs can be avoided [95]. Sal
k 5, a member of the Ole e 1-like protein family showed 30 %
sensitization prevalence and considerable high IgE cross-
reactivity with Che a 1 from chenopod [96]. Notably, this
IgE reactivity seems specific for Amaranthaceae and not re-
lated to Ole e 1 from olive pollen [96].
Che a 1 belongs to the Ole e 1-like family and presents a
sensitization frequency of >70 % among chenopod allergic
patients [89, 97]. High IgE reactivity to chenopod profilin
and polcalcin is noted, and diagnostic specificity was in-
creased by using a cocktail of three purified proteins [89].
However, the high IgE cross-reactivity of the panallergens
rather suggests that Che a 1 should be primarily considered
for diagnosis although discrimination from Russian thistle
sensitization seems challenging [64•, 98].
Annual Mercury
Annual mercury was reported to be an important source of
pollinosis in distinct regions of Mediterranean countries
[99]. For diagnostic purpose, the profilin Mer a 1 is currently
available in multiplex assays; however, due to high IgE cross-
reactivity with other pollen profilins, interpretation of these
results might be limited.
Pollen Panallergens
The term Bpanallergen^ refers to the ubiquitous distribution of
these allergens in diverse sources and profilins and polcalcins
are prototypic examples [100]. The clinical relevance is consid-
ered limited, but the broad IgE reactivity highly influences
extract-based diagnosis [92, 101••]. A panel of profilins and
polcalcins, considered representatives of the entire panallergen
group, is available for molecule-based diagnosis allowing dis-
crimination between genuine and panallergen sensitization
(Tables 1 and 2). For in vivo diagnosis, natural panallergens
from palm tree were previously used [102]. In contrast, mem-
bers of the pectate lyase, nsLTP, and Ole e 1-like families dem-
onstrate heterogeneous reactivity pattern. IgE cross-reactivity is
mostly confined to closely related molecules with high se-
quence identity andmight vary in different populations (Fig. 1).
Conclusions
Diagnosis of pollen allergies mainly relies on careful anamne-
sis, which includes narrowing down the sensitizing plant by
the time clinical symptoms are observed. However, flowering
periods are frequently overlapping and can vary in distinct
geographic regions while climatic changes are expected to
further aggravate the problem [1, 69, 70]. Pollen allergic
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patients are typically reacting to more than one source, thus
specific diagnosis is applied either using allergen extracts or
purified components. Based on molecule-based approaches,
more specific results are obtained and clinically irrelevant
sensitizations due to, e.g., panallergens or other IgE cross-
reactive compounds can be circumvented [11]. The currently
available panel of allergen components is coveringmost of the
common allergen sources; however, in comparison to extract-
based products, there is a substantial gap in quantity. Allergy
research will certainly further increase the panel of relevant
allergens of known sources as well as novel allergens from
plants that were less explored for diagnosis [37••]. Molecule-
based diagnosis can improve sensitivity, specificity, predict
severity of reactions, and identify the genuine sensitizing
source [103]. This refined diagnosis was recently shown to
change a large proportion of allergen immunotherapy pre-
scription as opposed to relying on anamnesis and SPT alone
[101••]. In future, allergy diagnosis using reliable biomarkers
might be crucial when considering allergen immunotherapy in
the context of precision medicine [104].
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